What is Viocare?
Established in 1993, Viocare Nutrition & Healthcare Research Solutions has carved out a significant niche in the development of customizable nutrition analysis software. The company provides sophisticated dietary assessment tools, most notably VioScreen Research and VioScreen Clinical, which offer validated, high-fidelity data for complex dietary tracking. Through long-standing collaborations with the National Institutes of Health and various academic research entities, Viocare has solidified its reputation as a provider of evidence-based solutions. Their platform serves as a critical infrastructure for researchers and healthcare providers who require precise, scalable, and reliable nutrition-based insights to drive wellness outcomes and clinical research integrity.
How much funding has Viocare raised?
Viocare has raised a total of $59K across 1 funding round:
Debt
$59K
Debt (2021): $59K with participation from PPP
Key Investors in Viocare
PPP
Public-Private Partnership
What's next for Viocare?
With the infusion of this recent capital, Viocare is expected to focus on scaling its digital health infrastructure and expanding its footprint within the clinical nutrition market. The strategic roadmap likely involves enhancing the interoperability of its VioScreen suite with modern electronic health records and expanding its custom solution offerings to meet the evolving demands of large-scale wellness programs. As the industry shifts toward personalized nutrition, Viocare's ability to synthesize complex dietary data into actionable clinical insights will be a primary driver of its future growth. The company remains well-positioned to capitalize on the increasing demand for data-driven health interventions, ensuring its continued relevance in the intersection of nutrition science and software engineering.
See full Viocare company page
